PSYB.F logo

PsyBio Therapeutics Corp. Stock Price

OTCPK:PSYB.F Community·US$132.0 Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

PSYB.F Share Price Performance

US$0.000001
0.00 (0.00%)
US$0.000001
0.00 (0.00%)
Price US$0.000001

PSYB.F Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Low risk with weak fundamentals.

3 Risks
0 Rewards

PsyBio Therapeutics Corp. Key Details

US$0

Revenue

US$50.0k

Cost of Revenue

-US$50.0k

Gross Profit

US$1.8m

Other Expenses

-US$1.9m

Earnings

Last Reported Earnings
Jun 30, 2023
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About PSYB.F

Founded
2009
Employees
n/a
CEO
Evan Levine
WebsiteView website
www.psybiolife.com

PsyBio Therapeutics Corp., a biotechnology company, engages in the research, development, and commercialization of psychedelic-inspired regulated medicines for the treatment of mental health and other disorders in the United States. PsyBio Therapeutics Corp. was formerly known as Leo Acquisitions Corp. and changed its name to PsyBio Therapeutics Corp. in January 2021. The company was incorporated in 2009 and is headquartered in Denver, Colorado.

Recent PSYB.F News & Updates

Recent updates

No updates